Cargando…
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
SIMPLE SUMMARY: Breast cancer is a heterogeneous disease, categorized into distinct subgroups with different clinical prognoses and treatment strategies. This study aimed to evaluate the role of ERBB3 in different molecular subtypes of breast cancers. Despite ERBB3/HER3 and its partner ERBB2/HER2 sh...
Autores principales: | Miano, Carmen, Morselli, Alessandra, Pontis, Francesca, Bongiovanni, Chiara, Sacchi, Francesca, Da Pra, Silvia, Romaniello, Donatella, Tassinari, Riccardo, Sgarzi, Michela, Pantano, Elvira, Ventura, Carlo, Lauriola, Mattia, D’Uva, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997077/ https://www.ncbi.nlm.nih.gov/pubmed/35406375 http://dx.doi.org/10.3390/cancers14071603 |
Ejemplares similares
-
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
por: Miano, Carmen, et al.
Publicado: (2022) -
Reawakening the Intrinsic Cardiac Regenerative Potential: Molecular Strategies to Boost Dedifferentiation and Proliferation of Endogenous Cardiomyocytes
por: Bongiovanni, Chiara, et al.
Publicado: (2021) -
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
por: Romaniello, Donatella, et al.
Publicado: (2022) -
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022) -
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
por: Romaniello, Donatella, et al.
Publicado: (2023)